Oncology Drugs Market Research Report, Growth & Forecast

Particle Therapy Market reached US$ 1.44 billion in 2025 and is expected to reach US$ 2.58 billion by 2033, growing with a CAGR of 7.90% during the forecast period 2026-2033. The Particle Therapy Mark...

Injectable Cytotoxic Drugs Market reached US$ 12.81 billion in 2025 and is expected to reach US$ 20.20 billion by 2033, growing with a CAGR of 5.90% during the forecast period 2026-2033. The Injectabl...

Leukemia Therapeutics Market reached US$ 18.87 billion in 2025 and is expected to reach US$ 31.37 billion by 2033, growing with a CAGR of 6.60% during the forecast period 2026-2033. The Leukemia Thera...

Myelofibrosis Therapeutics Marketis is growing with a CAGR of 7.60% during the forecast period 2026-2035. The Myelofibrosis Therapeutics Market emerges as a key focus in DataM Intelligence latest in-d...

... the location. “Global PARP Inhibitors Cancer Therapy Market, Price, Dosage & Clinical Pipeline Outlook 2023” report highlights: Current Market Trends & Development ... of BRCA 1 and BRCA 2 genes have an increased risk of certain types of cancer such as breast cancer, ovarian cancer and prostate cancer. Cells ...

The Global targeted cancer therapy market is anticipated to expand from USD 16.82 billion in 2025 to USD 26.26 billion by 2031, reflecting a compound annual growth rate of 7.71%. This precise medical...

Findings & Highlights: Global LAG-3 Targeting Therapy Market Opportunity: > USD 5 Billion By 2031Global Market Size Insight: 2022 Till 2031Approved LAG-3 Targeting Therapy Dosage, Pricing & Sales Ins...

Bispecific T-cell Engagers (BiTEs) Market reached US$ 2.63 Billion in 2025 and is expected to reach US$ 15.76 Billion by 2033, growing with a CAGR of 25.10% during the forecast period 2026-2033. The B...

The global AR PROTAC Degraders market size is predicted to grow from US$ million in 2025 to US$ 497 million in 2032; it is expected to grow at a CAGR of 19.3% from 2026 to 2032. No AR PROTAC Degraders...

The global AR PROTAC Drugs market size is predicted to grow from US$ million in 2025 to US$ 744 million in 2032; it is expected to grow at a CAGR of 25.2% from 2026 to 2032. No AR PROTAC drugs have ye...

The global Radiation Therapy Positioning Device market size is predicted to grow from US$ 319 million in 2025 to US$ 599 million in 2032; it is expected to grow at a CAGR of 9.6% from 2026 to 2032. Ra...

The global Radiotherapy Immobilization Device market size is predicted to grow from US$ 319 million in 2025 to US$ 599 million in 2032; it is expected to grow at a CAGR of 9.6% from 2026 to 2032. Radi...

Carcinoid Syndrome Diarrhea Treatment Marketis is growing with a CAGR of 9.80% during the forecast period 2026-2035. The Carcinoid Syndrome Diarrhea Treatment Market emerges as a key focus in DataM In...

Refractory Multiple Myeloma Market reached USD 2.75 Billion in 2025 and is expected to reach USD 4.08 Billion by 2033, growing with a CAGR of 4.70% during the forecast period 2026-2033. The Refractory...

Global Colorectal Cancer Drugs Marketis is growing with a CAGR of 5.20% during the forecast period 2026-2035. The Global Colorectal Cancer Drugs Market emerges as a key focus in DataM Intelligence lat...

According to Stratistics MRC, the Global Cancer Stem Cells Therapy Market is accounted for $6.9 billion in 2026 and is expected to reach $17.4 billion by 2034 growing at a CAGR of 12.2% during the for...

According to Stratistics MRC, the Global Capecitabine Market is accounted for $533.1 million in 2026 and is expected to reach $909.1 million by 2034 growing at a CAGR of 6.9% during the forecast perio...

According to Stratistics MRC, the Global Interventional Oncology Market is accounted for $3.1 billion in 2026 and is expected to reach $6.1 billion by 2034 growing at a CAGR of 8.8% during the forecas...

According to Stratistics MRC, the Global Neuroendocrine Tumor Treatment Market is accounted for $4007.0 million in 2026 and is expected to reach $12867.5 million by 2034 growing at a CAGR of 15.7% dur...

According to Stratistics MRC, the Global Proton Therapy Systems Market is accounted for $1.0 billion in 2026 and is expected to reach $1.8 billion by 2034 growing at a CAGR of 7.0% during the forecast...

Bone Cancer Marketis is growing with a CAGR of 5.00% during the forecast period 2026-2035. The Bone Cancer Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned...

Cancer Cachexia Marketis is growing with a CAGR of 6.80% during the forecast period 2026-2035. The Cancer Cachexia Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where s...

Diffuse Large B-cell Lymphoma Therapeutics Marketis is growing with a CAGR of 7.50% during the forecast period 2026-2035. The Diffuse Large B-cell Lymphoma Therapeutics Market emerges as a key focus i...

Gemcitabine HCL Marketis is growing with a CAGR of 7.00% during the forecast period 2026-2035. The Gemcitabine HCL Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where s...

Global Cancer Monoclonal Antibodies Market reached USD 63.37 Billion in 2025 and is expected to reach USD 149.36 Billion by 2033, growing with a CAGR of 11.40% during the forecast period 2026-2033. Th...

Pituitary Cancer Marketis is growing with a CAGR of 9.40% during the forecast period 2026-2035. The Pituitary Cancer Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where...

Prostate Cancer Market reached US$14.25 billion in 2025 and is expected to reach US$28.10 billion by 2033, growing with a CAGR of 7.80% during the forecast period 2026-2033. The Prostate Cancer Market...

Stomach Cancer Treatment Marketis is growing with a CAGR of 13.40% during the forecast period 2026-2035. The Stomach Cancer Treatment Market emerges as a key focus in DataM Intelligence latest in-dept...

Undifferentiated Pleomorphic Sarcoma Therapeutics Market reached USD 250 million in 2025 and is expected to reach USD 395 million by 2033, growing with a CAGR of 5.00% during the forecast period 2026-...

Urothelial Cancer Drugs Marketis is growing with a CAGR of 21.20% during the forecast period 2026-2035. The Urothelial Cancer Drugs Market emerges as a key focus in DataM Intelligence latest in-depth...

Merkel Cell Carcinoma Marketis is growing with a CAGR of 8.70% during the forecast period 2026-2035. The Merkel Cell Carcinoma Market emerges as a key focus in DataM Intelligence latest in-depth analy...

DDR Defective Tumors Market reached US$ 9.16 billion in 2025 and is expected to reach US$ 14.7 billion by 2033, growing with a CAGR of 7.00% during the forecast period 2026-2033. The DDR Defective Tum...

The Asia Pacific Cancer Drugs Market is projected to grow significantly, reaching an estimated US$ 99,289.8 million by 2031, up from US$ 38,552.1 million in 2024. This growth represents a compound ann...

The Asia Pacific Colorectal Cancer Treatment Market is projected to grow significantly, reaching approximately US$ 6,364.4 million by 2031, up from US$ 5,049.9 million in 2024, reflecting a compound a...

The Europe Cancer Drugs Market is projected to grow significantly, reaching approximately US$ 147,900.6 million by 2031, up from US$ 67,482.3 million in 2024. This growth represents a compound annual...

The Europe colorectal cancer treatment market is projected to grow significantly, reaching an estimated US$ 6,501.1 million by 2031, up from US$ 5,280.9 million in 2024, reflecting a compound annual g...

The Middle East and Africa (MEA) Cancer Drugs Market is projected to grow significantly, reaching an estimated US$ 8,816.2 million by 2031, up from US$ 4,415.8 million in 2024. This growth represents...

The Middle East & Africa (MEA) colorectal cancer treatment market is projected to grow significantly, reaching an estimated US$ 485.9 million by 2031, up from US$ 408.5 million in 2024, reflecting a c...

The North America Cancer Drugs Market is projected to grow significantly, reaching an estimated US$ 236,258.0 million by 2031, up from US$ 104,234.6 million in 2024. This growth reflects a compound an...

The North America Colorectal Cancer Treatment Market is projected to grow significantly, reaching approximately US$ 9,829.6 million by 2031, up from US$ 7,902.3 million in 2024, reflecting a compound...

The South and Central America Cancer Drugs Market is projected to grow significantly, reaching an estimated US$ 23,889.6 million by 2031, up from US$ 11,271.4 million in 2024. This growth represents a...

The South & Central America colorectal cancer treatment market is projected to grow significantly, reaching an estimated US$ 1,557.8 million by 2031, up from US$ 1,288.8 million in 2024, reflecting a...

Breast Cancer Treatment Market reached US$ 37.75 billion in 2024 and is expected to reach US$ 72.05 billion by 2033, growing with a CAGR of 9.40% during the forecast period 2026-2033. The Breast Cance...

According to Stratistics MRC, the Global Personalized Oncology & Immunotherapy Market is accounted for $180 billion in 2026 and is expected to reach $420 billion by 2034 growing at a CAGR of 11% durin...

The Androgen Receptor Inhibitor Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deli...

Immuno-Oncology (IO)-Thematic Intelligence Market reached USD 7.78 billion in 2025 and is expected to reach USD 21.53 billion by 2033, growing with a CAGR of 14.80% during the forecast period 2026-203...

Epithelioid Sarcoma Treatment Market reached US$ 1.58 billion in 2025 and is expected to reach US$ 3.19 billion by 2033, growing with a CAGR of 9.10% during the forecast period 2026-2033. The Epitheli...

The Pediatric Oncology Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver...

According to our (Global Info Research) latest study, the global Methotrexate API market size was valued at US$ 37.15 million in 2025 and is forecast to a readjusted size of US$ 47.17 million by 2032...

According to our (Global Info Research) latest study, the global Antibody-drug Conjugates for Tumors market size was valued at US$ 12142 million in 2025 and is forecast to a readjusted size of US$ 245...